)
2cureX (2CUREX) investor relations material
2cureX H1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Strengthened financial position through an oversubscribed directed share issue, raising approximately SEK 7.51 million before costs.
Advanced commercial development and prepared for decentralised IndiTreatⓇ hospital installations in H2 2026.
Entered a strategic collaboration with StoreMyTumor to enhance tumour logistics and patient coordination.
Evaluated a potential combination of 2cureX AB and 2cureX A/S to unify technology, people, and commercialisation efforts.
Following Nasdaq Stockholm's delisting decision, preparations for relisting on an alternative marketplace are underway.
Financial highlights
Oversubscribed directed share issue resulted in 6,541,736 new shares, increasing total shares to 31,644,652.
Financial figures for H1 2026 were deferred due to the transition to a new trading venue; figures will be provided as the relisting process advances.
Outlook and guidance
Focus on preparing IndiTreatⓇ for initial hospital installations and converting commercial discussions into contracts.
Continued disciplined capital allocation and securing financing for commercial execution.
Ongoing preparations for relisting on an alternative marketplace.
- Expanding into functional precision medicine with U.S. partnerships and a data-driven platform.2CUREX
Investor update - Strategic execution continued with no sales, a net loss, and key patient access milestones.2CUREX
H2 2025 - Direct-to-patient model validated, financials improved, and expansion accelerates in H1 2025.2CUREX
H1 2025 - Leadership changes and a new direct-to-patient strategy follow the sale of key assets.2CUREX
Investor update - Restructuring and new financing position 2cureX for a direct-to-patient oncology strategy.2CUREX
H1 2024 - Major restructuring and new strategy aim to revive growth after a year of losses.2CUREX
H2 2024
Next 2cureX earnings date
Next 2cureX earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)